Results
Six patients were excluded due to being less than 2 years old at the time of transplant, as GFR gradually increases during the first 2 years of life. There were 22 hyperfiltraters, making up 30% of the cohort. Median hyperfiltration GFR was 154 mL/min/1.73 m2 (IQR 146, 170). There were no associations between hyperfiltration and transplant demographics (Table 1 ). Eleven patients were excluded from outcomes evaluation due to low pre-SCT GFR (<90 mL/min/1.73 m2), and the outcomes of those with normal vs hyperfiltrating GFRs were compared. All of the 63 patients had 1 year follow up data; 37 patients had follow-up data past 2 years, for which the median follow up was 4.7 years. We found no association between baseline hyperfiltration and any of the outcomes (Table 1 ).